On December 14, CDER and Duke-Margolis will host a jointly sponsored virtual public meeting on advancing the development of therapeutics through rare disease patient community engagement.
The purpose of this public meeting is to highlight and build upon existing actionable approaches for engaging patients, patient groups, and related experts when developing necessary evidence to support rare disease drug approvals.
Registration and more information: https://healthpolicy.duke.edu/events/advancing-development-therapeutics-through-rare-disease-patient-community-engagement